Probióticos no controle do diabetes – perspectivas, benefícios diversificados e desafios emergentes: uma revisão integrativa

Autores

  • Islania Fablicia Felix dos Santos
  • Kellen França da Costa

DOI:

https://doi.org/10.51723/hrj.v6i30.981

Palavras-chave:

Diabetes mellitus; Probióticos; Suplementos dietéticos; Nutrição

Resumo

Objetivo: investigar os impactos dos probióticos em diferentes cenários relacionados ao diabetes. Método: revisão integrativa da literatura a partir das bases de dados BVS, PubMed e Scielo utilizando os Descritores em Ciência da Saúde (DeCS) “Dietary Supplements”, “Diabetes Mellitus”, “Probiotics”, combinados com o operador booleano AND. Resultados: os resultados abordam a eficácia variada dos probióticos em condições relacionadas ao diabetes, destacando benefícios significativos na redução da hemoglobina glicada, controle glicêmico em gestantes, melhorias no microbioma intestinal, e efeitos anti-inflamatórios. No entanto, ressalta-se a importância de considerar as especificidades das cepas utilizadas, bem como a necessidade de estudos mais abrangentes para compreender completamente o papel dos probióticos como terapia adjuvante no manejo do diabetes e condições relacionadas. Conclusões: desse modo, conclui-se que a implementação dos probióticos em intervenções relacionadas ao diabetes, evidenciando distintos benefícios, desde a melhora na hemoglobina glicada até a gestão eficaz da glicose em gestantes com diabetes gestacional. Contudo, ressalvas são necessárias, especialmente ao considerar o efeito adverso de certas formulações, como a berberina isolada, que desencadeou desconforto gástrico.

Referências

Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004 May;27(5):1047-53. doi: 10.2337/diacare.27.5.1047.

Walt G. WHO’s World Health Report 2003. BMJ. 2004 Jan 3;328(7430):6. doi: 10.1136/bmj.328.7430.6.

Malerbi DA, Franco LJ. Multicenter study of the prevalence of diabetes mellitus and impaired glucose tolerance in the urban Brazilian population aged 30-69 yr. The Brazilian Cooperative Group on the Study of Diabetes Prevalence. Diabetes Care. 1992 Nov;15(11):1509-16. doi: 10.2337/diacare.15.11.1509.

Bertoldi AD, Kanavos P, França GV, Carraro A, Tejada CA, Hallal PC et al. Epidemiology, management, complications and costs associated with type 2 diabetes in Brazil: a comprehensive literature review. Glob Health. 2013;9:62. doi:10.1186/1744-8603-9-62

Nutrição M. Departamento de Nutrição e Metabologia da SBD. 2009. Disponível em: https://diabetes.org.br/wp-content/uploads/2021/05/manual-de-nutri-para-pessoas-com-diabetes.pdf

Caroline A, Fonseca R. Educação alimentar e nutricional em pacientes portadores de Diabetes Mellitus tipo 2: uma revisão temática. Brasília, 04 de dezembro de 2015. Disponível em: https://bdm.unb.br/bitstream/10483/12876/1/2015_AnaCarolineRibeiroFonseca.pdf

Yuste A, Arosemena EL, Calvo MÀ. Study of the probiotic potential and evaluation of the survival rate of Lactiplantibacillus plantarum lyophilized as a function of cryoprotectant. Sci Rep. 2021 Sep 27;11(1):19078. doi: 10.1038/s41598-021-98723-0.

Sebastián Domingo JJ. Review of the role of probiotics in gastrointestinal diseases in adults. Gastroenterol Hepatol. 2017 Jun-Jul;40(6):417-429. English, Spanish. doi: 10.1016/j.gastrohep.2016.12.003.

Saarela M, Mogensen G, Fondén R, Mättö J, Mattila-Sandholm T. Probiotic bacteria: safety, functional and technological properties. J Biotechnol. 2000 Dec 28;84(3):197-215. doi: 10.1016/s0168-1656(00)00375-8.

Marette A, Picard-Deland E. Yogurt consumption and impact on health: focus on children and cardiometabolic risk. Am J Clin Nutr. 2014 May;99(5 Suppl):1243S-7S. doi: 10.3945/ajcn.113.073379.

Buhmann H, le Roux CW, Bueter M. The gut-brain axis in obesity. Best Pract Res Clin Gastroenterol. 2014 Aug;28(4):559-71. doi: 10.1016/j.bpg.2014.07.003.

Simons LA, Amansec SG, Conway P. Effect of Lactobacillus fermentum on serum lipids in subjects with elevated serum cholesterol. Nutr Metab Cardiovasc Dis. 2006 Dec;16(8):531-5. doi: 10.1016/j.numecd.2005.10.009.

Kassaian N, Feizi A, Aminorroaya A, Jafari P, Ebrahimi MT, Amini M. The effects of probiotics and synbiotic supplementation on glucose and insulin metabolism in adults with prediabetes: A double-blind randomized clinical trial. Acta Diabetol. 2018;55:1019-1028. doi: 10.1007/s00592-018-1175-2.

Kijmanawat A, Panburana P, Reutrakul S, Tangshewinsirikul C. Effects of probiotic supplements on insulin resistance in gestational diabetes mellitus: A double-blind randomized controlled trial. J Diabetes Investig. 2019 Jan;10(1):163-170. doi: 10.1111/jdi.12863. Epub 2018 Jun 30. Erratum in: J Diabetes Investig. 2019 Sep;10(5):1388.

Kobyliak N, Falalyeyeva T, Mykhalchyshyn G, Kyriienko D, Komissarenko I. Effect of alive probiotic on insulin resistance in type 2 diabetes patients: Randomized clinical trial. Diabetes Metab Syndr. 2018 Sep;12(5):617-624. doi: 10.1016/j.dsx.2018.04.015. Epub 2018 Apr 10.

Kumar S, Kumar R, Rohilla L, Jacob N, Yadav J, Sachdeva N. A high potency multi-strain probiotic improves glycemic control in children with new-onset type 1 diabetes mellitus: A randomized, double-blind, and placebo-controlled pilot study. Pediatr Diabetes. 2021 Nov;22(7):1014-1022. doi: 10.1111/pedi.13244.

Tonucci LB, Dos Santos KMO, Oliveira LL, Ribeiro SMR, Martino HSD. Clinical application of probiotics in type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled study. Clin Nutr. 2017;36(1):85-92. doi:10.1016/j.clnu.2015.11.011.

Wang S, Ren H, Zhong H, Zhao X, Li C, Ma J, et al. Combined berberine and probiotic treatment as an effective regimen for improving postprandial hyperlipidemia in type 2 diabetes patients: a double-blinded placebo-controlled randomized study. Gut Microbes. 2022;14(1):2003176. doi:10.1080/19490976.2021.2003176.

Amirani E, Asemi Z, Taghizadeh M. The effects of selenium plus probiotics supplementation on glycemic status and serum lipoproteins in patients with gestational diabetes mellitus: A randomized, double-blind, placebo-controlled trial. Clin Nutr ESPEN. 2022 Apr;48:56-62. doi: 10.1016/j.clnesp.2022.02.010

Karamali M, Dadkhah F, Sadrkhanlou M, Jamilian M, Ahmadi S, Tajabadi-Ebrahimi M, Jafari P, Asemi Z. Effects of probiotic supplementation on glycaemic control and lipid profiles in gestational diabetes: A randomized, double-blind, placebo-controlled trial. Diabetes Metab. 2016 Sep;42(4):234-41. doi: 10.1016/j.diabet.2016.04.009.

Zhang Y, Gu Y, Ren H, Wang S, Zhong H, Zhao X, Ma J, Gu X, Xue Y, Huang S, Yang J, Chen L, Chen G, Qu S, Liang J, Qin L, Huang Q, Peng Y, Li Q, Wang X, Kong P, Hou G, Gao M, Shi Z, Li X, Qiu Y, Zou Y, Yang H, Wang J, Xu G, Lai S, Li J, Ning G, Wang W. Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study). Nat Commun. 2020 Oct 6;11(1):5015. doi: 10.1038/s41467-020-18414-8.

Callaway LK, McIntyre HD, Barrett HL, Foxcroft K, Tremellen A, Lingwood BE, et al. Probiotics for the prevention of gestational diabetes mellitus in overweight and obese women: findings from the SPRING double-blind randomized controlled trial. Diabetes Care. 2019;42(3):364-71. doi:10.2337/dc18-2248.

Kanazawa A, Aida M, Yoshida Y, Kaga H, Katahira T, Suzuki L, Tamaki S, Sato J, Goto H, Azuma K, Shimizu T, Takahashi T, Yamashiro Y, Watada H. Effects of Synbiotic Supplementation on Chronic Inflammation and the Gut Microbiota in Obese Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Study. Nutrients. 2021 Feb 8;13(2):558. doi: 10.3390/nu13020558.

Palacios T, Vitetta L, Coulson S, Madigan CD, Lam YY, Manuel R, Briskey D, Hendy C, Kim JN, Ishoey T, Soto-Giron MJ, Schott EM, Toledo G, Caterson ID. Targeting the Intestinal Microbiota to Prevent Type 2 Diabetes and Enhance the Effect of Metformin on Glycaemia: A Randomised Controlled Pilot Study. Nutrients. 2020 Jul 9;12(7):2041. doi: 10.3390/nu12072041.

Pellonperä O, Mokkala K, Houttu N, Vahlberg T, Koivuniemi E, Tertti K, Rönnemaa T, Laitinen K. Efficacy of Fish Oil and/or Probiotic Intervention on the Incidence of Gestational Diabetes Mellitus in an At-Risk Group of Overweight and Obese Women: A Randomized, Placebo-Controlled, Double-Blind Clinical Trial. Diabetes Care. 2019 Jun;42(6):1009-1017. doi: 10.2337/dc18-2591.

Hasanpour A, Babajafari S, Mazloomi SM, Shams M. The effects of soymilk plus probiotics supplementation on cardiovascular risk factors in patients with type 2 diabetes mellitus: a randomized clinical trial. BMC Endocr Disord. 2023 Feb 10;23(1):36. doi: 10.1186/s12902-023-01290-w.

Shabani-Mirzaee H, Haghshenas Z, Malekiantaghi A, Vigeh M, Mahdavi F, Eftekhari K. The effect of oral probiotics on glycated haemoglobin levels in children with type 1 diabetes mellitus - a randomized clinical trial. Pediatr Endocrinol Diabetes Metab. 2023;29(3):128-133. doi: 10.5114/pedm.2023.132025.

Ziegler MC, Garbim Junior EE, Jahnke VS, Moura JGL, Brasil CS, Cunha PHS, et al. Impact of probiotic supplementation in a patient with type 2 diabetes on glycemic and lipid profile. Clin Nutr ESPEN. 2022;49:264-9. doi:10.1016/j.clnesp.2022.04.002

Sabico S, Al-Mashharawi A, Al-Daghri NM, Wani K, Amer OE, Hussain DS, et al. Effects of a 6-month multistrain probiotics supplementation in endotoxemic, inflammatory and cardiometabolic status of T2DM patients: a randomized, double-blind, placebo-controlled trial. Clin Nutr. 2019;38(4):1561-9. doi:10.1016/j.clnu.2018.08.009.

Nabrdalik K, Drożdż K, Kwiendacz H, Skonieczna-Żydecka K, Łoniewski I, Kaczmarczyk M, Wijata AM, Nalepa J, Holleman F, Nieuwdorp M, Gumprecht J. Clinical Trial: Probiotics in Metformin Intolerant Patients with Type 2 Diabetes (ProGasMet). Biomed Pharmacother. 2023 Dec;168:115650. doi: 10.1016/j.biopha.2023.115650.

Razmpoosh E, Javadi A, Ejtahed HS, Mirmiran P, Javadi M, Yousefinejad A. The effect of probiotic supplementation on glycemic control and lipid profile in patients with type 2 diabetes: A randomized placebo controlled trial. Diabetes Metab Syndr. 2019 Jan-Feb;13(1):175-182. doi:10.1016/j.dsx.2018.08.008.

Hata S, Nakajima H, Hashimoto Y, Miyoshi T, Hosomi Y, Okamura T, Majima S, Nakanishi N, Senmaru T, Osaka T, Okada H, Ushigome E, Hamaguchi M, Asano M, Yamazaki M, Fukui M. Effects of probiotic Bifidobacterium bifidum G9-1 on the gastrointestinal symptoms of patients with type 2 diabetes mellitus treated with metformin: An open-label, single-arm, exploratory research trial. J Diabetes Investig. 2022 Mar;13(3):489-500. doi: 10.1111/jdi.13698.

Bianchini S, Orabona C, Camilloni B, Berioli MG, Argentiero A, Matino D, Alunno A, Albini E, Vacca C, Pallotta MT, Mancini G, Tascini G, Toni G, Mondanelli G, Silvestri E, Grohmann U, Esposito S. Effects of probiotic administration on immune responses of children and adolescents with type 1 diabetes to a quadrivalent inactivated influenza vaccine. Hum Vaccin Immunother. 2020;16(1):86-94. doi:10.1080/21645515.2019.1633877.

Groele L, Szajewska H, Szalecki M, Świderska J, Wysocka-Mincewicz M, Ochocińska A, Stelmaszczyk-Emmel A, Demkow U, Szypowska A. Lack of effect of Lactobacillus rhamnosus GG and Bifidobacterium lactis Bb12 on beta-cell function in children with newly diagnosed type 1 diabetes: a randomised controlled trial. BMJ Open Diabetes Res Care. 2021 Mar;9(1):e001523. doi: 10.1136/bmjdrc-2020-001523.

Zikou E, Dovrolis N, Dimosthenopoulos C, Gazouli M, Makrilakis K. The Effect of Probiotic Supplements on Metabolic Parameters of People with Type 2 Diabetes in Greece-A Randomized, Double-Blind, Placebo Controlled Study. Nutrients. 2023 Nov 3;15(21):4663. doi:10.3390/nu15214663.

Raygan F, Ostadmohammadi V, Asemi Z. The effects of probiotic and selenium co-supplementation on mental health parameters and metabolic profiles in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial. Clin Nutr. 2019 Aug;38(4):1594-1598. doi: 10.1016/j.clnu.2018.07.017.

Madempudi RS, Ahire JJ, Neelamraju J, Tripathi A, Nanal S. Efficacy of UB0316, a multi-strain probiotic formulation in patients with type 2 diabetes mellitus: A double blind, randomized, placebo controlled study. PLoS One. 2019 Nov 13;14(11):e0225168. doi:10.1371/journal.pone.0225168.

Horvath A, Leber B, Feldbacher N, Tripolt N, Rainer F, Blesl A, Trieb M, Marsche G, Sourij H, Stadlbauer V. Effects of a multispecies synbiotic on glucose metabolism, lipid marker, gut microbiome composition, gut permeability, and quality of life in diabesity: a randomized, double-blind, placebo-controlled pilot study. Eur J Nutr. 2020 Oct;59(7):2969-2983. doi: 10.1007/s00394-019-02135-w.

Zhang X, Fu C, An Q, Bai J, Jia L. Effects of probiotic supplements on insulin resistance in patients with diet-controlled gestational diabetes mellitus. Journal of Medical Postgraduates. 2020;609-12.

Hajifaraji M, Jahanjou F, Abbasalizadeh F, Aghamohammadzadeh N, Abbasi MM, Dolatkhah N. Effect of probiotic supplements in women with gestational diabetes mellitus on inflammation and oxidative stress biomarkers: a randomized clinical trial. Asia Pac J Clin Nutr. 2018;581-91. Available from: https://pesquisa.bvsalud.org/portal/resource/pt/mdl-2973780

Downloads

Publicado

2025-05-30

Como Citar

Fablicia Felix dos Santos, I., & França da Costa, K. . (2025). Probióticos no controle do diabetes – perspectivas, benefícios diversificados e desafios emergentes: uma revisão integrativa. Health Residencies Journal, 6(30). https://doi.org/10.51723/hrj.v6i30.981